Neose Technologies, Inc. is developing manufacturing processes based on its enzymatic glycosylation technology platform. The Company intends to use these processes to manufacture enzymes and sugar nucleotides for use by its potential GlycoAdvance customers, as well as for its own use in manufacturing complex carbohydrates for the GlycoAdvance, GlycoTherapeutics and GlycoActives programs